Concepedia

Publication | Closed Access

Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis

86

Citations

31

References

2008

Year

Abstract

The data demonstrate that AS602868-mediated IKK2 inhibition represents a new therapeutic approach to prevent dietary-induced NASH progression.

References

YearCitations

Page 1